Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-12

FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION — Original Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved a generic travoprost ophthalmic solution (ANDA) from Gland Pharma Limited, expanding access to a prostaglandin analog for reducing elevated intraoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRAVOPROST OPHTHALMIC SOLUTION (Travoprost)

Snippet

ORIG AP for TRAVOPROST OPHTHALMIC SOLUTION (TRAVOPROST OPHTHALMIC SOLUTION)